Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07404787 · ClinicalTrials.gov registry record · NA

Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Hospitalization

A NA study, sponsored by Uniformed Services University of the Health Sciences.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target

NCT07404787 is a NA study that is actively recruiting participants, run by Uniformed Services University of the Health Sciences. The registered enrollment target is 1,500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07404787, a NA study, is actively recruiting participants, sponsored by Uniformed Services University of the Health Sciences.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target

Study Summary

This study evaluates the effectiveness of Pathfinding, a 6-month, remotely-delivered case management intervention designed to decrease suicidal behavior among active-duty Regular Army soldiers recently discharged from inpatient psychiatric treatment. Soldiers discharged from military treatment facilities across the U.S. will be identified and recruited to participate. Those who consent will be randomly assigned to receive either Treatment As Usual (TAU), which is the Army's standard post-discharge care, or TAU plus Pathfinding. Participants will complete a baseline assessment and follow-up assessments 6 months and 12 months later. The 6- and 12-month follow-up periods will also include examination of participants' electronic healthcare data and Army administrative data. The overall goals of the study are: (1) to evaluate whether Pathfinding decreases suicidal behaviors among soldiers transitioning from psychiatric hospitalization back to the community; and (2) to determine which discharged soldiers are most likely to benefit from the Pathfinding intervention versus TAU alone.

Interventions

  • BEHAVIORAL Treatment As Usual (TAU)
  • BEHAVIORAL Pathfinding

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2026-02-24
Est. Completion 2029-08-31
Phase NA

What the Registry Record Tells You About NCT07404787

The ClinicalTrials.gov registry entry for NCT07404787 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Uniformed Services University of the Health Sciences, which has 27 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Treatment As Usual (TAU) is the first listed.

NCT07404787 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07404787 about?

NCT07404787 is a clinical study titled "Evaluation of a Telehealth Case Management Intervention to Prevent Suicide Among Soldiers Discharged From Psychiatric Hospitalization". This study evaluates the effectiveness of Pathfinding, a 6-month, remotely-delivered case management intervention designed to decrease suicidal behavior among active-duty Regular Army soldiers recently discharged from inpatient psychiatric treatment. Soldiers discharged from military treatment facil...

What is the current status of trial NCT07404787?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2026-02-24. Estimated completion is 2029-08-31.

What interventions are being tested in trial NCT07404787?

The interventions under investigation include: Treatment As Usual (TAU) (BEHAVIORAL), Pathfinding (BEHAVIORAL).

Who is sponsoring clinical trial NCT07404787?

This trial is sponsored by Uniformed Services University of the Health Sciences, which has 27 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.